News

HealthCap V Portfolio Company Targovax Completes NOK 200 Private Placement

HealthCap V portfolio company Targovax ASA has announced a successful NOK 200 million private placement, in which HealthCap V L.P. has committed to participate with NOK 25 million. HealthCap is the largest shareholder in Targovax with 22%, fully diluted, following the private placement, but prior to the repair offering of up to an additional NOK …

HealthCap V Portfolio Company Targovax Completes NOK 200 Private Placement Read More »

Final price in BONESUPPORT™’s initial public offering set at SEK 29 per share – trading on Nasdaq Stockholm commences today

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE To read original article, please visit the Bone Support Site  Stockholm, 21 June, 2017  BONESUPPORT HOLDING …

Final price in BONESUPPORT™’s initial public offering set at SEK 29 per share – trading on Nasdaq Stockholm commences today Read More »

CAPIO ACQUIRES A SWEDISH EYE SPECIALIST CLINIC IN STOCKHOLM

Capio has signed an agreement to acquire 100% of the shares in Globen Ögonklinik (PanSyn Sweden AB, including subsidiaries) (“Globen”). The clinic is specialized in ophthalmology and offers complex eye treatments, including cataract surgery, RLE (Refractive Lens Exchange) and refractive laser treatments. Net sales in 2016 were MSEK 75. Globen provides ophthalmology treatments at two …

CAPIO ACQUIRES A SWEDISH EYE SPECIALIST CLINIC IN STOCKHOLM Read More »

Altimmune Completes Merger with PharmAthene Creating Immunotherapeutics Company Targeting Infectious Diseases

Gaithersburg, MD, May 4, 2017 – Altimmune, Inc. (Nasdaq: ALT) announced today the completion of its merger with PharmAthene, Inc., effective May 4, 2017. Upon the completion of the merger, the combined company was renamed Altimmune, Inc., and will commence trading on The NASDAQ Capital Market under the ticker symbol “ALT” on May 5, 2017. …

Altimmune Completes Merger with PharmAthene Creating Immunotherapeutics Company Targeting Infectious Diseases Read More »

HealthCap’s 39th IPO – HealthCap V Company MIPS AB Starts Trading Today on Nasdaq OMX Stockholm

Swedish HealthCap V portfolio company MIPS AB has successfully completed its oversubscribed Initial Public Offering on Nasdaq OMX Stockholm’s main market. The total deal size is EUR 59 million (SEK 570 million) of which the company is raising EUR 15 million (SEK 150 million) in gross proceeds. HealthCap and other major investors committed to sell …

HealthCap’s 39th IPO – HealthCap V Company MIPS AB Starts Trading Today on Nasdaq OMX Stockholm Read More »

PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases

January 19, 2017 6:30 AM ET ANNAPOLIS, Md. and GAITHERSBURG, Md., Jan. 19, 2017 /PRNewswire/ — PharmAthene, Inc. (NYSE MKT: PIP) and Altimmune, Inc., a privately-held immunotherapeutics company targeting infectious diseases, announced today the signing of a definitive agreement for the merger of PharmAthene and Altimmune in an all-stock transaction. Altimmune’s current investors include Novartis …

PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases Read More »

Tieto Press Release

Tieto strengthens its position as a business renewal partner for financial services customers – acquires Emric Tieto has signed an agreement to acquire Emric, the Nordic market leader in software and services for credit processing. The acquisition will strengthen Tieto’s position as a business renewal partner for Nordic financial services customers. It is expected to …

Tieto Press Release Read More »

Foundation of a Bengt Samuelsson research insitute in China

A research Institute in China in the name of our Senior Advisor Bengt Samuelsson, Professor of Physiological Chemistry and former President of the Karolinska Institute. . Professor Samuelsson was awarded the Nobel Prize in 1982 for his research. Significant funding has been made available to the research institute which will focus on the incubation and …

Foundation of a Bengt Samuelsson research insitute in China Read More »

Presidio Partners Announces New Fund, Unveils New Corporate Identity, and Announces Additional Senior Management

Peter Gajdos Tapped as Managing Director, Lee Pantuso as CFO, Firm Announces Presidio Partners 2014 Fund SAN FRANCISCO, April 21, 2015 – Presidio Partners, formerly CMEA Capital, today unveiled a new corporate identity, announced the promotion of Peter Gajdos to the role of Managing Director and the appointment of Lee Pantuso as Chief Financial Officer, …

Presidio Partners Announces New Fund, Unveils New Corporate Identity, and Announces Additional Senior Management Read More »

Scroll to Top